Oxford Biomedica Plc (OXBDF)
7.15
0.00 (0.00%)
USD |
OTCM |
Sep 04, 16:00
Oxford Biomedica 1 Year Total Returns (Daily) : -2.72% for Sept. 4, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| September 04, 2026 | -2.72% |
| September 03, 2026 | -2.72% |
| September 02, 2026 | -2.72% |
| September 01, 2026 | -2.72% |
| August 31, 2026 | -2.72% |
| August 28, 2026 | -2.72% |
| August 27, 2026 | -2.72% |
| August 26, 2026 | -2.72% |
| August 25, 2026 | -2.04% |
| August 24, 2026 | -2.04% |
| August 21, 2026 | -5.11% |
| August 20, 2026 | 3.63% |
| August 19, 2026 | 2.41% |
| August 18, 2026 | 2.41% |
| August 17, 2026 | 2.41% |
| August 14, 2026 | 9.90% |
| August 13, 2026 | 17.25% |
| August 12, 2026 | 17.25% |
| August 11, 2026 | 16.51% |
| August 10, 2026 | 16.51% |
| August 07, 2026 | 16.51% |
| August 06, 2026 | 17.63% |
| August 05, 2026 | 11.21% |
| August 04, 2026 | 21.93% |
| August 03, 2026 | 28.00% |
| Date | Value |
|---|---|
| July 31, 2026 | 32.89% |
| July 30, 2026 | 32.78% |
| July 29, 2026 | 54.74% |
| July 28, 2026 | 54.74% |
| July 27, 2026 | 54.74% |
| July 24, 2026 | 54.74% |
| July 23, 2026 | 54.74% |
| July 22, 2026 | 53.38% |
| July 21, 2026 | 55.58% |
| July 20, 2026 | 73.00% |
| July 17, 2026 | 59.80% |
| July 16, 2026 | 67.51% |
| July 15, 2026 | 67.51% |
| July 14, 2026 | 67.51% |
| July 13, 2026 | 67.51% |
| July 10, 2026 | 67.51% |
| July 09, 2026 | 67.51% |
| July 08, 2026 | 71.83% |
| July 07, 2026 | 72.15% |
| July 06, 2026 | 88.89% |
| July 02, 2026 | 87.35% |
| July 01, 2026 | 87.35% |
| June 30, 2026 | 85.32% |
| June 29, 2026 | 85.32% |
| June 26, 2026 | 85.32% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Bicycle Therapeutics Plc | -38.31% |
| Roivant Sciences Ltd. | 177.9% |
| Adaptimmune Therapeutics Plc | -47.45% |
| Kiniksa Pharmaceuticals International Plc | 119.4% |
| Autolus Therapeutics Plc | 54.48% |